Modification of gene expression induced by siRNA targeting of estrogen receptor alpha in MCF7 human breast cancer

Y A Luqmani1, A Al Azmi, M Al Bader

  • 1Faculty of Pharmacy, Kuwait University, Safat 13110, Kuwait. yunus@hsc.edu.kw

Insights

Researchers developed an endocrine-resistant breast cancer model by reducing estrogen receptor (ER) levels in MCF7 cells. This model exhibits reduced ER activity and altered gene expression, offering insights into endocrine independence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Endocrine resistance is a major challenge in breast cancer treatment.
  • Loss of estrogen receptor (ER) function is a key mechanism driving endocrine resistance.
  • Developing reliable models is crucial for studying endocrine-resistant breast cancer.

Purpose of the Study:

  • To establish a cellular model of endocrine-resistant breast cancer associated with estrogen receptor (ER) loss.
  • To analyze the molecular and genetic changes accompanying ER loss and endocrine resistance.

Main Methods:

  • MCF7 breast cancer cells were transfected to reduce ERalpha mRNA and protein levels using siRNA.
  • Stably transformed cells (pII line) were cultured long-term and analyzed.
  • Gene expression profiling was performed using real-time PCR and microarray analysis.

Main Results:

  • The pII cell line showed significantly reduced ERalpha mRNA and protein, leading to unresponsiveness to estradiol and tamoxifen.
  • Increased ERbeta levels were observed, while EGFR family members showed decreased expression.
  • Microarray analysis revealed altered expression of numerous genes, including decreased keratins (KRT19, KRT18) and increased vimentin (VIM) and CD68, suggesting an epithelial-mesenchymal transition.

Conclusions:

  • The pII cell line serves as a valuable model for studying ER-loss-driven endocrine resistance in breast cancer.
  • The observed gene expression changes, including epithelial-mesenchymal transition markers, provide new insights into the mechanisms of endocrine independence.
  • Further characterization of this model may elucidate factors controlling growth in endocrine-independent cells.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...